Cellectis (CLLS) Other Accumulated Expenses (2013 - 2026)

Cellectis' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 25.21% year-over-year to $8.2 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 25.21% increase from a year earlier, with the FY2025 full-year figure at $12.3 million, up 22.23% from the prior year.
• Other Accumulated Expenses declined to $8.2 million in Q1 2026 per CLLS's latest filing, from $12.3 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $13.2 million in Q4 2022 and bottomed at $6.1 million in Q1 2023.
• The 5-year median for Other Accumulated Expenses is $9.9 million (2025), against an average of $9.6 million.
• Across the five-year window, Other Accumulated Expenses sank 34.06% in 2023 and increased 25.21% in 2026, its largest moves.
• Year by year, Other Accumulated Expenses stood at $13.2 million in 2022, then dropped by 22.46% to $10.2 million in 2023, then fell by 1.19% to $10.1 million in 2024, then increased by 22.23% to $12.3 million in 2025, then plunged by 33.4% to $8.2 million in 2026.
• Per Business Quant, the three latest CLLS Other Accumulated Expenses figures stand at $8.2 million (Q1 2026), $12.3 million (Q4 2025), and $10.8 million (Q3 2025).